25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MIRA (MIRA Pharmaceuticals, Inc. Common Stock) Stock Analysis
Buy, Hold or Sell?

Let's analyze MIRA Pharmaceuticals, Inc. Common Stock together

I guess you are interested in MIRA Pharmaceuticals, Inc. Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – MIRA Pharmaceuticals, Inc. Common Stock’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – MIRA Pharmaceuticals, Inc. Common Stock’s Price Targets

I'm going to help you getting a better view of MIRA Pharmaceuticals, Inc. Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about MIRA Pharmaceuticals, Inc. Common Stock

I send you an email if I find something interesting about MIRA Pharmaceuticals, Inc. Common Stock.

1. Quick Overview

1.1. Quick analysis of MIRA Pharmaceuticals, Inc. Common Stock (30 sec.)










1.2. What can you expect buying and holding a share of MIRA Pharmaceuticals, Inc. Common Stock? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.13
Expected worth in 1 year
$-0.22
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.36
Return On Investment
-38.0%

For what price can you sell your share?

Current Price per Share
$0.94
Expected price per share
$0.7401 - $1.49
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of MIRA Pharmaceuticals, Inc. Common Stock (5 min.)




Live pricePrice per Share (EOD)
$0.94

2.2. Growth of MIRA Pharmaceuticals, Inc. Common Stock (5 min.)




Is MIRA Pharmaceuticals, Inc. Common Stock growing?

Current yearPrevious yearGrowGrow %
How rich?$2.1m$2.5m$279.8k10.0%

How much money is MIRA Pharmaceuticals, Inc. Common Stock making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$2m$101.8k5.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of MIRA Pharmaceuticals, Inc. Common Stock (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of MIRA Pharmaceuticals, Inc. Common Stock?

Welcome investor! MIRA Pharmaceuticals, Inc. Common Stock's management wants to use your money to grow the business. In return you get a share of MIRA Pharmaceuticals, Inc. Common Stock.

First you should know what it really means to hold a share of MIRA Pharmaceuticals, Inc. Common Stock. And how you can make/lose money.

Speculation

The Price per Share of MIRA Pharmaceuticals, Inc. Common Stock is $0.9389. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of MIRA Pharmaceuticals, Inc. Common Stock.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in MIRA Pharmaceuticals, Inc. Common Stock, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.13. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of MIRA Pharmaceuticals, Inc. Common Stock.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.14-15.4%-0.11-12.2%-0.12-13.3%-0.11-12.2%-0.11-12.2%
Usd Book Value Change Per Share-0.08-8.8%-0.09-9.5%0.1818.7%0.021.8%0.021.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-8.8%-0.09-9.5%0.1818.7%0.021.8%0.021.8%
Usd Price Per Share1.14-1.04-1.55-1.10-1.10-
Price to Earnings Ratio-1.97--2.33--1.79--1.84--1.84-
Price-to-Total Gains Ratio-13.74--6.38-11.13--2.88--2.88-
Price to Book Ratio8.58-6.56-3.16-4.46-4.46-
Price-to-Total Gains Ratio-13.74--6.38-11.13--2.88--2.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9389
Number of shares1065
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.090.02
Usd Total Gains Per Share-0.090.02
Gains per Quarter (1065 shares)-95.1017.68
Gains per Year (1065 shares)-380.4270.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-380-39007161
20-761-7700141132
30-1141-11500212203
40-1522-15300283274
50-1902-19100354345
60-2283-22900424416
70-2663-26700495487
80-3043-30500566558
90-3424-34300637629
100-3804-38100707700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.08.00.00.0%0.08.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.05.00.037.5%3.05.00.037.5%3.05.00.037.5%3.05.00.037.5%
Dividend per Share0.00.04.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.03.00.025.0%3.05.00.037.5%3.05.00.037.5%3.05.00.037.5%3.05.00.037.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of MIRA Pharmaceuticals, Inc. Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.083-0.089+8%0.175-147%0.017-600%0.017-600%
Book Value Per Share--0.1330.161-17%0.151-12%0.133+0%0.133+0%
Current Ratio--3.9924.869-18%2.424+65%3.389+18%3.389+18%
Debt To Asset Ratio--0.2470.211+17%2.096-88%1.104-78%1.104-78%
Debt To Equity Ratio--0.3290.272+21%0.769-57%0.425-23%0.425-23%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--18156077.00020067189.250-10%81973614.000-78%32448474.200-44%32448474.200-44%
Eps---0.145-0.114-21%-0.125-14%-0.114-21%-0.114-21%
Ev To Ebitda Ratio--infinfnan%-6.485nan%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.109-0.081-25%-0.070-35%-0.074-32%-0.074-32%
Free Cash Flow To Equity Per Share---0.079-0.024-70%0.111-171%0.031-357%0.031-357%
Gross Profit Margin--1.0001.388-28%1.0000%1.194-16%1.194-16%
Market Cap15549029.010-21%18879426.00018159130.250+4%25669395.000-26%18705588.250+1%18705588.250+1%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio7.069-21%8.5836.557+31%3.163+171%4.465+92%4.465+92%
Pe Ratio-1.620+18%-1.967-2.329+18%-1.789-9%-1.835-7%-1.835-7%
Price Per Share0.939-21%1.1401.044+9%1.550-26%1.103+3%1.103+3%
Price To Free Cash Flow Ratio-2.154+18%-2.615-3.438+31%-3.644+39%-3.085+18%-3.085+18%
Price To Total Gains Ratio-11.317+18%-13.741-6.376-54%11.130-223%-2.875-79%-2.875-79%
Quick Ratio---3.739-100%2.256-100%2.748-100%2.748-100%
Return On Assets---0.821-0.578-30%-1.367+67%-0.998+22%-0.998+22%
Return On Equity---1.091-0.742-32%-0.500-54%-0.559-49%-0.559-49%
Total Gains Per Share---0.083-0.089+8%0.175-147%0.017-600%0.017-600%
Usd Book Value--2199750.0002787309.750-21%2507484.667-12%2259432.625-3%2259432.625-3%
Usd Book Value Change Per Share---0.083-0.089+8%0.175-147%0.017-600%0.017-600%
Usd Book Value Per Share--0.1330.161-17%0.151-12%0.133+0%0.133+0%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--18156077.00020067189.250-10%81973614.000-78%32448474.200-44%32448474.200-44%
Usd Eps---0.145-0.114-21%-0.125-14%-0.114-21%-0.114-21%
Usd Free Cash Flow---1805030.000-1390151.500-23%-1165796.000-35%-1254178.750-31%-1254178.750-31%
Usd Free Cash Flow Per Share---0.109-0.081-25%-0.070-35%-0.074-32%-0.074-32%
Usd Free Cash Flow To Equity Per Share---0.079-0.024-70%0.111-171%0.031-357%0.031-357%
Usd Market Cap15549029.010-21%18879426.00018159130.250+4%25669395.000-26%18705588.250+1%18705588.250+1%
Usd Price Per Share0.939-21%1.1401.044+9%1.550-26%1.103+3%1.103+3%
Usd Profit---2399696.000-1963164.750-18%-2064989.000-14%-1924638.125-20%-1924638.125-20%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.083-0.089+8%0.175-147%0.017-600%0.017-600%
 EOD+3 -5MRQTTM+7 -25YOY+6 -255Y+10 -2210Y+10 -22

3.3 Fundamental Score

Let's check the fundamental score of MIRA Pharmaceuticals, Inc. Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.620
Price to Book Ratio (EOD)Between0-17.069
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than13.992
Debt to Asset Ratio (MRQ)Less than10.247
Debt to Equity Ratio (MRQ)Less than10.329
Return on Equity (MRQ)Greater than0.15-1.091
Return on Assets (MRQ)Greater than0.05-0.821
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of MIRA Pharmaceuticals, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.816
Ma 20Greater thanMa 500.982
Ma 50Greater thanMa 1001.045
Ma 100Greater thanMa 2001.121
OpenGreater thanClose0.990
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About MIRA Pharmaceuticals, Inc. Common Stock

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

Fundamental data was last updated by Penke on 2025-04-05 12:02:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ MIRA Pharmaceuticals, Inc. Common Stock earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ MIRA Pharmaceuticals, Inc. Common Stock is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • -82.1% Return on Assets means thatΒ MIRA Pharmaceuticals, Inc. Common Stock generatedΒ $-0.82 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is -82.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -57.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-82.1%TTM-57.8%-24.3%
TTM-57.8%YOY-136.7%+78.9%
TTM-57.8%5Y-99.8%+42.0%
5Y-99.8%10Y-99.8%0.0%
4.3.1.3. Return on Equity

Shows how efficient MIRA Pharmaceuticals, Inc. Common Stock is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • -109.1% Return on Equity means MIRA Pharmaceuticals, Inc. Common Stock generated $-1.09Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is -109.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -74.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-109.1%TTM-74.2%-34.9%
TTM-74.2%YOY-50.0%-24.2%
TTM-74.2%5Y-55.9%-18.4%
5Y-55.9%10Y-55.9%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of MIRA Pharmaceuticals, Inc. Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient MIRA Pharmaceuticals, Inc. Common Stock is operatingΒ .

  • Measures how much profit MIRA Pharmaceuticals, Inc. Common Stock makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient MIRA Pharmaceuticals, Inc. Common Stock is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of MIRA Pharmaceuticals, Inc. Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if MIRA Pharmaceuticals, Inc. Common Stock is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • A Current Ratio of 3.99Β means the company has $3.99 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 3.992. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.869. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.992TTM4.869-0.877
TTM4.869YOY2.424+2.445
TTM4.8695Y3.389+1.480
5Y3.38910Y3.3890.000
4.4.3.2. Quick Ratio

Measures if MIRA Pharmaceuticals, Inc. Common Stock is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.739-3.739
TTM3.739YOY2.256+1.483
TTM3.7395Y2.748+0.992
5Y2.74810Y2.7480.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of MIRA Pharmaceuticals, Inc. Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of MIRA Pharmaceuticals, Inc. Common StockΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.25Β means that MIRA Pharmaceuticals, Inc. Common Stock assets areΒ financed with 24.7% credit (debt) and the remaining percentage (100% - 24.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.247. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.211. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.247TTM0.211+0.036
TTM0.211YOY2.096-1.885
TTM0.2115Y1.104-0.892
5Y1.10410Y1.1040.000
4.5.4.2. Debt to Equity Ratio

Measures ifΒ MIRA Pharmaceuticals, Inc. Common Stock is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 32.9% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.329. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.272. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.329TTM0.272+0.057
TTM0.272YOY0.769-0.497
TTM0.2725Y0.425-0.152
5Y0.42510Y0.4250.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings MIRA Pharmaceuticals, Inc. Common Stock generates.

  • Above 15 is considered overpriced butΒ always compareΒ MIRA Pharmaceuticals, Inc. Common Stock to theΒ Drug Manufacturers - General industry mean.
  • A PE ratio of -1.97 means the investor is paying $-1.97Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The EOD is -1.620. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.967. Based on the earnings, the company is expensive. -2
  • The TTM is -2.329. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.620MRQ-1.967+0.347
MRQ-1.967TTM-2.329+0.362
TTM-2.329YOY-1.789-0.540
TTM-2.3295Y-1.835-0.494
5Y-1.83510Y-1.8350.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The EOD is -2.154. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.615. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.438. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.154MRQ-2.615+0.461
MRQ-2.615TTM-3.438+0.823
TTM-3.438YOY-3.644+0.205
TTM-3.4385Y-3.085-0.353
5Y-3.08510Y-3.0850.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ MIRA Pharmaceuticals, Inc. Common Stock is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 8.58 means the investor is paying $8.58Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MIRA Pharmaceuticals, Inc. Common Stock:

  • The EOD is 7.069. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.583. Based on the equity, the company is overpriced. -1
  • The TTM is 6.557. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.069MRQ8.583-1.514
MRQ8.583TTM6.557+2.025
TTM6.557YOY3.163+3.394
TTM6.5575Y4.465+2.092
5Y4.46510Y4.4650.000
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of MIRA Pharmaceuticals, Inc. Common Stock.

4.8.3. Insider Transactions

Insiders are holding 23.325% of the shares of MIRA Pharmaceuticals, Inc. Common Stock.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-19Erez AminovSELL554101.39
2024-05-21Erez AminovBUY87000.94
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,923
Total Liabilities723
Total Stockholder Equity2,200
 As reported
Total Liabilities 723
Total Stockholder Equity+ 2,200
Total Assets = 2,923

Assets

Total Assets2,923
Total Current Assets2,888
Long-term Assets35
Total Current Assets
Cash And Cash Equivalents 2,833
Total Current Assets  (as reported)2,888
Total Current Assets  (calculated)2,833
+/- 55
Long-term Assets
Long-term Assets  (as reported)35
Long-term Assets  (calculated)0
+/- 35

Liabilities & Shareholders' Equity

Total Current Liabilities723
Long-term Liabilities0
Total Stockholder Equity2,200
Total Current Liabilities
Accounts payable 723
Total Current Liabilities  (as reported)723
Total Current Liabilities  (calculated)723
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)2,200
Total Stockholder Equity (calculated)0
+/- 2,200
Other
Capital Stock2
Common Stock Shares Outstanding 16,561
Net Invested Capital 2,200
Net Working Capital 2,164



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
0
0
0
858
398
3,825
9,018
3,809
3,016
4,267
2,923
2,9234,2673,0163,8099,0183,825398858000
   > Total Current Assets 
2,223
0
0
494
251
421
6,071
3,714
2,932
4,231
2,888
2,8884,2312,9323,7146,071421251494002,223
       Cash And Cash Equivalents 
0
0
0
351
1
25
5,868
3,529
2,824
4,145
2,833
2,8334,1452,8243,5295,868251351000
       Net Receivables 
0
0
0
0
0
0
0
12
0
0
0
000120000000
       Other Current Assets 
100
0
0
0
60
43
203
185
109
87
0
0871091852034360000100
   > Long-term Assets 
0
0
0
364
147
3,404
2,947
95
83
35
35
353583952,9473,404147364000
       Property Plant Equipment 
194
0
0
364
147
132
114
1
0
0
0
000111413214736400194
       Long-term Assets Other 
0
0
0
0
0
3,222
2,783
0
83
35
0
0358302,7833,22200000
> Total Liabilities 
0
0
0
1,454
2,187
2,629
903
652
797
693
723
7236937976529032,6292,1871,454000
   > Total Current Liabilities 
534
0
0
1,370
2,119
2,577
868
652
797
693
723
7236937976528682,5772,1191,37000534
       Short-term Debt 
0
0
0
407
292
1,878
74
1
0
0
0
0001741,878292407000
       Short Long Term Debt 
0
0
0
133
220
1,803
0
0
0
0
0
000001,803220133000
       Accounts payable 
210
0
0
812
1,104
645
511
636
782
693
723
7236937826365116451,10481200210
       Other Current Liabilities 
0
0
0
151
722
54
-227
14
14
693
0
06931414-22754722151000
   > Long-term Liabilities 
0
0
0
84
68
51
35
0
0
0
0
000035516884000
       Deferred Long Term Liability 
0
0
0
0
0
3,222
0
0
0
0
0
000003,22200000
> Total Stockholder Equity
0
0
0
-596
-1,789
1,197
8,115
3,157
2,219
3,574
2,200
2,2003,5742,2193,1578,1151,197-1,789-596000
   Common Stock
7
0
0
7
7
7
1
1
1
2
0
02111777007
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
-135
0
0
8,700
8,848
13,100
23,612
26,158
26,912
30,310
0
030,31026,91226,15823,61213,1008,8488,70000-135



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-8,018
Operating Income-8,018-8,018
 
Operating Expense (+$)
Research Development3,306
Selling General Administrative4,713
Selling And Marketing Expenses0
Operating Expense8,0188,018
 
Net Interest Income (+$)
Interest Income0
Interest Expense-166
Other Finance Cost-331
Net Interest Income166
 
Pretax Income (+$)
Operating Income-8,018
Net Interest Income166
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,853-8,018
EBIT - interestExpense = -166
-7,853
-7,687
Interest Expense166
Earnings Before Interest and Taxes (EBIT)0-7,687
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-7,853
Tax Provision-0
Net Income From Continuing Ops-7,853-7,853
Net Income-7,853
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-166
 

Technical Analysis of MIRA Pharmaceuticals, Inc. Common Stock
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of MIRA Pharmaceuticals, Inc. Common Stock. The general trend of MIRA Pharmaceuticals, Inc. Common Stock is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine MIRA Pharmaceuticals, Inc. Common Stock's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. MIRA Pharmaceuticals, Inc. Common Stock Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MIRA Pharmaceuticals, Inc. Common Stock.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.328 < 1.33 < 1.49.

The bearish price targets are: 0.8 > 0.75 > 0.7401.

Know someone who trades $MIRA? Share this with them.πŸ‘‡

MIRA Pharmaceuticals, Inc. Common Stock Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MIRA Pharmaceuticals, Inc. Common Stock. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MIRA Pharmaceuticals, Inc. Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MIRA Pharmaceuticals, Inc. Common Stock. The current macd is -0.04427183.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MIRA Pharmaceuticals, Inc. Common Stock price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for MIRA Pharmaceuticals, Inc. Common Stock. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the MIRA Pharmaceuticals, Inc. Common Stock price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MIRA Pharmaceuticals, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MIRA Pharmaceuticals, Inc. Common Stock. The current adx is 24.62.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy MIRA Pharmaceuticals, Inc. Common Stock shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
MIRA Pharmaceuticals, Inc. Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MIRA Pharmaceuticals, Inc. Common Stock. The current sar is 0.751898.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MIRA Pharmaceuticals, Inc. Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MIRA Pharmaceuticals, Inc. Common Stock. The current rsi is 46.82. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
MIRA Pharmaceuticals, Inc. Common Stock Daily Relative Strength Index (RSI) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MIRA Pharmaceuticals, Inc. Common Stock. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the MIRA Pharmaceuticals, Inc. Common Stock price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
MIRA Pharmaceuticals, Inc. Common Stock Daily Stochastic Oscillator ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MIRA Pharmaceuticals, Inc. Common Stock. The current cci is -35.11199363.

MIRA Pharmaceuticals, Inc. Common Stock Daily Commodity Channel Index (CCI) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MIRA Pharmaceuticals, Inc. Common Stock. The current cmo is -2.58131954.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
MIRA Pharmaceuticals, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MIRA Pharmaceuticals, Inc. Common Stock. The current willr is -66.29937278.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that MIRA Pharmaceuticals, Inc. Common Stock is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MIRA Pharmaceuticals, Inc. Common Stock Daily Williams %R ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of MIRA Pharmaceuticals, Inc. Common Stock.

MIRA Pharmaceuticals, Inc. Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MIRA Pharmaceuticals, Inc. Common Stock. The current atr is 0.11661243.

MIRA Pharmaceuticals, Inc. Common Stock Daily Average True Range (ATR) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MIRA Pharmaceuticals, Inc. Common Stock. The current obv is 322,032,256.

MIRA Pharmaceuticals, Inc. Common Stock Daily On-Balance Volume (OBV) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MIRA Pharmaceuticals, Inc. Common Stock. The current mfi is 95.38.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
MIRA Pharmaceuticals, Inc. Common Stock Daily Money Flow Index (MFI) ChartMIRA Pharmaceuticals, Inc. Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MIRA Pharmaceuticals, Inc. Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

MIRA Pharmaceuticals, Inc. Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MIRA Pharmaceuticals, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.816
Ma 20Greater thanMa 500.982
Ma 50Greater thanMa 1001.045
Ma 100Greater thanMa 2001.121
OpenGreater thanClose0.990
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of MIRA Pharmaceuticals, Inc. Common Stock with someone you think should read this too:
  • Are you bullish or bearish on MIRA Pharmaceuticals, Inc. Common Stock? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about MIRA Pharmaceuticals, Inc. Common Stock? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MIRA Pharmaceuticals, Inc. Common Stock

I send you an email if I find something interesting about MIRA Pharmaceuticals, Inc. Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about MIRA Pharmaceuticals, Inc. Common Stock.

Receive notifications about MIRA Pharmaceuticals, Inc. Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.